Anthony J. Gill

Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profiles

Mucinous cystic neoplasms and simple mucinous cysts are two distinct precursors of pancreatic cancer: clinicopathological, genomic, and transcriptomic characterization

Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies

Assessment and classification of sex cord‐stromal tumours of the testis: recommendations from the testicular sex cord‐stromal tumour (<scp>TESST</scp>) group, an Expert Panel of the Genitourinary Pathology Society (<scp>GUPS</scp>) and International Society of Urological Pathology (<scp>ISUP</scp>)

Spatial Transcriptomics Reveals Novel Mechanisms Involved in Perineural Invasion in Pancreatic Ductal Adenocarcinomas

Automated deep learning-based assessment of tumour-infiltrating lymphocyte density determines prognosis in colorectal cancer

Observer Variation in the Diagnosis of Testicular Sex Cord-Stromal Tumors by a Genitourinary Pathology Society and International Society of Urological Pathology Panel: Paving the Way for a New Classification

The Brescia International Multidisciplinary Consensus Guidelines on the Optimal Pathology Assessment and Multidisciplinary Pathways of Non‐Pancreatic Neoplasms in and Around the Ampulla of Vater (PERIPAN)

<scp>WHO</scp> classification of skin tumours: key updates in the fifth edition

The genomic and evolutionary landscapes of anaplastic thyroid carcinoma

A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer

Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study

The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Lymphocyte-to-Monocyte Ratio (LMR) as Biomarkers in Resected Pancreatic Cancer

The 5th Edition of the World Health Organization Classification of Tumours of the Eye and Orbit

A Detailed Histologic and Molecular Assessment of the Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma

A Critical Assessment of Diagnostic Criteria for the Tall Cell Subtype of Papillary Thyroid Carcinoma—How Much? How Tall? And When Is It Relevant?

Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single‐cell analysis

Data from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes

The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours

Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas

Overview of the 2022 WHO Classification of Parathyroid Tumors

Neoantigen quality predicts immunoediting in survivors of pancreatic cancer

<scp>WHO</scp> 2022 landscape of papillary and chromophobe renal cell carcinoma

Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment

Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes

<scp>WHO</scp>Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer

Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas

Histopathological tumour response scoring in resected pancreatic cancer following neoadjuvant therapy: international interobserver study (ISGPP-1)

Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes

Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification